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Abstract
The rhoptry of the malaria parasite Plasmodium falciparum is an unusual secretory organelle that is thought to be related to
secretory lysosomes in higher eukaryotes. Rhoptries contain an extensive collection of proteins that participate in host cell
invasion and in the formation of the parasitophorous vacuole, but little is known about sorting signals required for rhoptry
protein targeting. Using green fluorescent protein chimeras and in vitro pull-down assays, we performed an analysis of the
signals required for trafficking of the rhoptry protein RAP1. We provide evidence that RAP1 is escorted to the rhoptry via an
interaction with the glycosylphosphatidyl inositol-anchored rhoptry protein RAMA. Once within the rhoptry, RAP1 contains
distinct signals for localisation within a sub-compartment of the organelle and subsequent transfer to the parasitophorous
vacuole after invasion. This is the first detailed description of rhoptry trafficking signals in Plasmodium.
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Introduction
Malaria is a disease that causes severe morbidity, mortality and
socio-economic hardship in tropical and sub-tropical areas of
Africa, South America and Asia. Plasmodium falciparum causes the
most serious form of the disease and is responsible for more than 2
million deaths annually [1–3]. The development and implemen-
tation of novel intervention strategies in the form of drugs, vector
control measures and an effective vaccine remains an urgent
global health priority [4].
Plasmodium spp. belong to the phylum Apicomplexa – protozoan
parasites characterised by a complex lifecycle consisting of
invasion followed by rounds of intracellular replication. The
invasion is mediated by a set of molecules distributed on the
parasite surface and within specialised apical secretory organelles.
Regulated secretion from these organelles allows the parasite to
adhere to an appropriate target cell, invade and induce the
formation of a specialised parasitophorous vacuole (PV) in which it
subsequently resides (reviewed in [5]).
Rhoptries are the largest of the Plasmodium secretory organelles
and contain more than 20 proteins, many of which are unusual
and have no recognisable orthologues, even in the closely related
apicomplexan parasite Toxoplasma gondii (reviewed in [6]). Rhop-
tries are pear-shaped and membrane bound, and in transmission
electron micrographs the bulb and neck appear to form distinct
sub-compartments. The neck is electron-lucent while the bulb is
electron-dense and contains internal membranes reminiscent of
multivesicular endosomes in higher eukaryotes [7–9]. Individual
proteins are not distributed throughout the rhoptry but are sub-
compartmentalised within either the bulb or the neck [10–12].
Rhoptry biogenesis occurs by sequential fusion of Golgi-derived
vesicles which deliver protein cargo into the rhoptry lumen [9,13].
Rhoptry proteins pass through the endoplasmic reticulum (ER)
and the Golgi [14,15], but specific targeting signals which direct
protein sorting into rhoptry destined vesicles remain poorly
understood. In mammalian cells, sorting of transmembrane
proteins is mediated by cytoplasmic adaptor complexes (APs)
which recognise specific motifs (e.g. the YXXW motif, where W is a
hydrophobic amino acid) within their cytoplasmic tails. APs select
cargo for inclusion into a transport vesicle and recruit coat
components (e.g. clathrin) necessary for vesicular budding and
transport [16,17]. This mechanism has been shown to operate in
Toxoplasma, and may also be conserved in Plasmodium [18,19].
However, most Plasmodium rhoptry proteins described to date do
not possess a transmembrane region and cytoplasmic tail, implying
the existence of additional sorting pathways [6].
One possibility is that sorting within the Golgi occurs via a
clustering mechanism whereby proteins en route to a particular
destination aggregate into distinct sub-domains [20]. The rhoptry
associated membrane antigen (RAMA) is a glycosylphosphatidyl
inositol (GPI)-anchored protein that is expressed early in the
asexual red blood cell (RBC) cycle. Most rhoptry proteins are
expressed at the late trophozoite stage but RAMA is first
synthesised during the late ring stage, before the appearance of
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within compartments of the secretory pathway [15]. This unusual
expression pattern suggests that RAMA may be involved in
rhoptry biogenesis and protein targeting. Fluorescence Resonance
Energy Transfer (FRET) experiments indicate that RAMA
interacts with the low molecular weight (LMW) rhoptry complex
[15]. The LMW complex is a heterodimer composed of rhoptry
associated protein 1 (RAP1), and RAP2 or RAP3 [21]. Rhoptry
targeting of the LMW complex occurs via the N-terminus of
RAP1, although the mechanism is not understood [22]. We
hypothesised that RAMA acts as an escorter for RAP1 to recruit
RAP1, 22 and 23 into a rhoptry-destined protein complex.
Here we have used expression of heterologous reporter
constructs and pull-down assays to map the RAP1 targeting
signals and define the RAMA-RAP1 interaction. Our results
provide evidence of a novel mechanism for trafficking of proteins
to this unusual secretory organelle.
Results
RAP1 contains a bipartite rhoptry targeting signal
In P. falciparum schizont stage parasites, RAP1 is localised in the
rhoptry bulb [21,23]. Previously, it has been shown that the first
344 amino acids of RAP1 are sufficient for rhoptry targeting [22].
To more precisely define these targeting signals, we used
constructs consisting of regions of RAP1 fused to green fluorescent
protein (GFP). GFP was chosen as a reporter because it has
previously been used in a variety of studies in Plasmodium and does
not possess any endogenous targeting signals. When expressed on
its own, GFP localises to the parasite cytoplasm. However,
addition of sorting signals can result in trafficking of GFP to
compartments of the secretory system [24,25]. The expression of
RAP1-GFP chimeras was driven by an inducible promoter with a
pattern of expression similar to merozoite surface protein 2
(MSP2) [26]. A late stage promoter was selected to avoid aberrant
targeting as a result of incorrect timing of expression [27,28].
To verify that GFP could be trafficked to rhoptries, we initially
generated two constructs – GFP fused to amino acids 1-344 of
RAP1 (RAP1-344) and GFP fused to the entire RAP1 sequence
(RAP1-FL). The constructs were introduced into P. falciparum 3D7
parasites and the trafficking of GFP was followed using
fluorescence microscopy (Figure 1A). As expected, both constructs
produced a punctate pattern of staining in schizonts, characteristic
of localisation within the apical secretory organelles. Surprisingly
however, the two constructs demonstrated subtly different
localisation patterns. For RAP1-FL, GFP fluorescence co-localised
with the rhoptry bulb marker RAMA [15], and mimicked the
localisation of native RAP1 in wild-type parasites (Figure 1Aii and
1Aiii). In contrast, for RAP1-344, GFP staining only partially
overlapped and was anterior to a larger RAMA-positive structure
(Figure 1Ai). To ascertain the precise localisation of the RAP1-
344GFP chimera, we performed double labelling experiments with
PfRON4 (a rhoptry neck marker) [29] and apical membrane
antigen 1 (AMA1, a microneme marker) [30] using specific
antibodies (Figure 1B). Our results strongly suggest that for RAP1-
344, GFP is not localised in micronemes (Figure 1Bi) but is
localised in the rhoptry neck (Figure 1Bii).
To explore whether rhoptry neck localisation of truncated
RAP1 was an artefact of our heterologous expression system, we
reanalysed the original rap1 truncation mutant (D10DRAP1)[22].
This mutant, generated by single cross-over homologous recom-
bination in the parasite line D10, has a truncated rap1 gene
expressing amino acids 1-344 of RAP1 under the control of its
native promoter. Interestingly, the same pattern was observed for
D10DRAP1 as for RAP1-344, with GFP co-localising with
PfRON4 (Figure 1Biii). To further confirm this finding, we
localised RAP1 in D10DRAP1 and its parent line using
immunoelectron microscopy (Figure 1C). In D10, native RAP1
is localised in the rhoptry bulb, whereas in D10DRAP1 the
truncated RAP1 protein is localised in the rhoptry neck, adjacent
to PfRON4. Taken together, this data strongly suggests that RAP1
contains a bi-partite rhoptry signal: amino acids 1-344 are
sufficient for targeting RAP1 to the rhoptry and amino acids
344-782 are necessary to avoid re-localisation of the protein from
the bulb of the rhoptries to the neck.
Amino acids 22-55 of RAP1 are sufficient for targeting
GFP to the rhoptries
Having confirmed the ability of RAP1-344 to target GFP to the
rhoptries, we set out to define the minimal region sufficient for
rhoptry targeting. To this end, we generated a series of N-terminal
RAP1 truncation-GFP fusions (Figure 2A and S1). RAP1-244,
RAP1-144, RAP1-65 and RAP1-55 were all able to direct
trafficking of GFP to the rhoptries. In contrast, for the RAP1-35
construct, GFP fluorescence produced a ‘cluster of grapes’ pattern.
Co-localisation with serine repeat antigen 5 (SERA5) (Figure 2Aiii),
confirmed that RAP1-35-GFP was targeted to the parasitophorous
vacuole (PV), the default destination for the secretory pathway
[24,25]. RAP1 possesses a typical N-terminal signal sequence that
is presumably cleaved upon entry into the ER [31]. SignalP
analysis of the RAP1 sequence predicts that this cleavage occurs
between amino acids 21 and 22. Replacement of the RAP1 signal
sequence with a signal sequence from the acyl carrier protein
(ACP – normally targeted to the apicoplast) [24] had no effect on
rhoptry localisation (Figure 2B). Our data strongly suggests that
the signal sequence of RAP1 directs the protein into the secretory
pathway. Information contained in amino acids 22-55 (hereafter
referred to as the RAP1 rhoptry signal) is then sufficient to divert
the protein to the rhoptries.
Amino acids 22-55 of RAP1 are necessary for optimal
rhoptry targeting
In T. gondii, proteins that are targeted to the rhoptries can
contain multiple signals that are independently sufficient but not
Author Summary
The malaria parasite Plasmodium falciparum is a eukaryotic
organism with multiple membrane bound organelles with
discrete functions. The rhoptry is an unusual secretory
organelle that participates in host cell invasion and the
formation of a specialised vacuole that the parasite
occupies during the intracellular part of its lifecycle.
Rhoptries contain an extensive collection of proteins, but
little is known about how these proteins are trafficked to
their destination. Understanding determinants of rhoptry
protein trafficking will help us to identify novel rhoptry
proteins, and may provide targets for therapeutic inter-
vention. In the current study, we focussed on the
trafficking of the rhoptry protein RAP1. By making
parasites that express regions of RAP1 fused to Green
Fluorescent Protein (GFP), we were able to map in detail
the domains of RAP1 that are necessary for correct
trafficking. We also provide evidence that RAP1 is targeted
to rhoptries via its interaction with another rhoptry
protein, RAMA. This is the first detailed description of
rhoptry trafficking signals in Plasmodium.
Rhoptry Trafficking in P. falciparum
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this is the case for RAP1, we generated a construct that contains
the ACP signal peptide fused to amino acids 56-782 of RAP1 (i.e.
the entire RAP1 sequence lacking the signal peptide and the
rhoptry signal) fused to GFP (Figure 2C). Although this construct
was partially targeted to discrete foci that co-localised with
RAMA, the bulk of the fluorescence was distributed in the PV.
This data suggests that amino acids 22-55 of RAP1 are necessary
for optimal targeting to the rhoptries.
The N-terminus of RAP1 interacts with RAMA in vitro
Having defined the RAP1 rhoptry signal, we were interested in
the mechanism by which this region mediates targeting. Since
RAMA is refractory to genetic deletion [34], we were unable to
study the trafficking of RAP1 in RAMA deletion mutants.
Furthermore, repeated attempts to overexpress full length RAMA,
or RAMA lacking various domains (e.g. R1, R2 or R3 repeats)
failed (results not shown), presumably due to toxic effects of
overexpression of this protein. Instead, we decided to map the
RAMA-RAP1 interaction in vitro. We reasoned that if RAMA acts
as an escorter for the LMW complex, it should interact with the
RAP1 rhoptry signal which is responsible for correct targeting of
the complex. To test this hypothesis, we initially made a
recombinant His6-tagged RAP1 protein representing amino acids
22-152 (RAP1(22-152)), which contains within it the RAP1
rhoptry signal, and used it in a pull-down assay (Figure 3). Our
results indicate that RAP1(22-152) but not MSP4 (an irrelevant
His6-tagged protein) bound RAMA in a schizont stage parasite
extract (Figure 3A). To confirm these findings and more precisely
map the RAP1 binding site within RAMA, we made RAMA-GST
fusion proteins representing amino acids 482-758 (RAMAD), 759-
840 (RAMAE), 759-798 (RAMAE1) and 799-840 (RAMAE2). We
used these proteins together with RAP1(22-152) in pull-down
assays (Figure 3B). RAMAE and RAMAE1 both bound to
RAP1(22-152), whilst GST alone did not bind. Truncation of the
C-terminus of RAP1(22-152) did not affect RAMAE binding,
whereas deletion of the RAP1 rhoptry signal from RAP1(22-152)
(construct RAP1(57-152)) abolished RAMAE binding (Figure 3C).
Taken together these results demonstrate that the RAP1 rhoptry
signal, involved in the targeting of the LMW complex to the
rhoptries, acts as the binding site for the C-terminus of RAMA.
Mutation of aromatic amino acids that affect the RAP1-
RAMA interaction also affect RAP1 targeting
We had mapped the RAP1 rhoptry signal and the RAMA
binding site to the N-terminus of RAP1. Due to low expression
levels of RAP1-GFP chimeras we could not directly confirm
RAMA binding by immunoprecipitation. Instead, we made a
series of RAP1(22-152) mutant proteins and tested them in pull-
down assays against RAMAE (Figure 4A). The same amino acids
were also mutated in the RAP1-55 targeting construct so that their
affect on RAP1 targeting in vivo could be examined (Figure 4B and
S2) We focussed on residues 30–55 as these contain at least part of
the information required for correct trafficking of RAP1. Amino
acid alignment of RAP1 orthologues from different Plasmodium spp.
failed to identify any potential conserved motifs within the RAP1
rhoptry signal (data not shown). Mutation of negatively charged
residues (aspartate 39, 43 and 44) to either non-polar (alanine) or
positively charged (arginine) residues failed to disrupt either
rhoptry targeting or RAMA binding (Figure 4ii and 4iii). By
contrast, mutation of aromatic residues (at positions 40, 42, 45, 47
and 48) to glycine abolished the RAMA-RAP1 interaction and
resulted in mistargeting of GFP to the PV (Figure 4iv).
To analyse the individual importance of each of the aromatic
residues we made mutants where only some of the aromatic
residues were changed to glycines. Mutation of residues 40, 42,
and 45 was insufficient to alter either RAMA binding or in vivo
targeting (Figure 4Av and 4Bv). Simultaneous mutation of residues
40, 42, 45 and 47 or 47 and 48 abolished RAMA binding
(Figure 4Avi and 4Avii). The same mutations in the RAP1-55
targeting constructs resulted in significant mistargeting of GFP to
the PV, although some chimeric GFP could be observed in
rhoptries (Figure 4Bvi and 4Bvii). This is likely a reflection of the
sensitivity of the in vitro assay. In vivo, the reduced affinity of the
interaction results in partial mistargeting, whereas in vitro the
interaction falls below detectable levels. These results indicate that
although residues 47 (tyrosine) and 48 (tryptophan) play a
significant role in RAP1 targeting, it is the overall nature of the
RAP1 rhoptry signal that is important.
Proteolytic processing of the RAMA-RAP complex
The interaction between RAMA and RAP1 in vivo was initially
demonstrated by FRET, a technique that measures photon
transfer between two fluorophores that are in close proximity
[15]. In our attempts to affinity purify the RAMA-RAP complex
from schizont stage parasites, we found that only a small amount
of RAMA co-precipitated with RAP1, and vice versa (results not
shown). This data is consistent with previous studies [21,35–37],
and suggests that the RAMA-RAP interaction is transient. Both
RAMA and RAP1 are synthesised as pre-proteins that are
proteolytically processed within nascent rhoptries, presumably by
a rhoptry-resident protease [15,38]. We hypothesised that this
processing may serve to dissociate the transient RAMA-RAP
complex. The N-terminal pro-peptide of RAMA is unusually large
and comprises more than 50% of the entire protein [15]. The N-
terminus of the mature RAMA protein (RAMA p60) has recently
been mapped using N-terminal sequencing (cleavage occurs
between residues 477L and 478Q). Analysis of RAMA orthologues
from different Plasmodium spp. indicates that the protease
responsible for this cleavage recognises the sequence (D/
E)SFL(Q/E) [39]. We examined the primary structure of RAMA
and found that this sequence and/or closely related sequences are
repeated eight times within the pro-peptide region but are not
present within RAMA p60 (Figure 5). A putative cleavage site was
also identified at amino acids 67-71 (ESFLE) of RAP1. Cleavage of
the RAP1 pro-peptide has been mapped upstream of A124 and
involves the removal of approximately 40 amino acids (in addition
to the signal peptide) [38]. We attempted N-terminal sequencing
of immunoaffinity-purified RAP1, but did not obtain any data
presumably due to N-terminal blockage of the protein. We also
Figure 1. RAP1 contains a bipartite rhoptry signal. (A) RAP1-344 and RAP1-FL GFP fusions. Both constructs show a punctate fluorescence
pattern characteristic of rhoptry localisation. For the RAP1-FL construct, GFP signal overlaps with RAMA. In contrast, the RAP1-344GFP chimera only
partially overlaps with RAMA, suggesting rhoptry neck localisation. (B) For the RAP1-344 construct, GFP co-localises with the rhoptry neck marker
PfRON4 and does not co-localise with the microneme marker AMA1. Likewise in the transgenic parasite line D10DRAP1, truncated RAP1 co-localises
with PfRON4. (C) Immunoelectron microscopy demonstrates that truncated RAP1 (10 nm beads) in D10DRAP1 parasites is localised in the rhoptry
neck, whereas full-length RAP1 in D10 (wild-type) parasites is localised in the rhoptry bulb. PfRON4 (15 nm beads) is localised in the rhoptry neck in
both parasite lines.
doi:10.1371/journal.ppat.1000328.g001
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spectrometry (LC-MS) analysis. In two independent analyses, we
obtained .60% coverage of RAP1 downstream of the putative
cleavage site, but did not detect any peptides upstream of the
cleavage site. The most N-terminal peptide detected corresponded
to amino acids 74-91 of RAP1 (results not shown). The peptide
corresponding to amino acids 71-73 (which would be present if
cleavage occurs between 70L and 71E) is too small to be detected.
This data, in combination with previously published data, strongly
suggests that both RAMA and RAP1 are processed by the same
rhoptry-resident protease.
Amino acids 344-444 of RAP1 contain a PV transfer motif
Many, though not all, rhoptry proteins are secreted during
merozoite invasion and are transferred to the PV of nascent ring
stage parasites where they presumably play a role in the
establishment of the PV membrane [40]. Earlier studies using
D10DRAP1, have demonstrated that full length RAP1 is
transferred to the PV during invasion, whereas truncated RAP1
is not [22]. Given our finding that the C-terminus of RAP1
contains a rhoptry bulb retention motif (see above), it is possible
that RAP1 secretion is dependent on correct sub-organellar
localisation. To more precisely map the signals within RAP1
required for rhoptry bulb retention and PV transfer, we generated
a further series of RAP1 truncation-GFP fusions that included
regions of the C-terminus of the protein. These parasites were
examined by fluorescence microscopy both at schizont stage (to
establish rhoptry bulb or rhoptry neck localisation) and at ring
stage (to ascertain transfer to the PV). As expected, RAP1-
344GFP, which is localised in the rhoptry neck (Figure 1Bii), was
not transferred to the PV during invasion (Figure 6i). In contrast,
for the full-length RAP1, RAP1-644 and RAP1-544 constructs,
Figure 3. RAP1 recombinant proteins bind RAMA in pull-down assays. (A) RAP1(22-152) but not MSP4 (negative control) binds native RAMA
p60 in parasite lysate. Binding of RAMA was detected by immunoblotting using anti-RAMA antibodies. (B) RAP1(22-152) binds to RAMAE and
RAMAE1 GST-fusion proteins but not to the GST control. (C) Deletion of the RAP1 rhoptry signal from RAP1(22-152) abolishes binding of RAMAE.
Schematics of RAMA and RAP1 fragments are shown; SS, signal sequence.
doi:10.1371/journal.ppat.1000328.g003
Figure 2. Amino acids 22-55 of RAP1 are sufficient and necessary for rhoptry targeting. (A) A series of RAP1 truncation-GFP fusions. The
RAP1-344 and RAP1-55 constructs show a punctate fluorescence pattern characteristic of rhoptry localisation. GFP signal partially overlaps with RAMA
staining, suggesting localisation in the rhoptry neck. For the RAP1-35 construct, GFP is trafficked to the PV as confirmed by co-localisation with
SERA5. (B) Replacement of the predicted signal peptide in the RAP1-144 targeting construct with the ACP signal peptide (ACPspRAP23-144) has no
effect on rhoptry localisation. (C) Fluorescence microscopy on parasites transfected with the ACPspRAP56-FL construct using fixed cells (i) or live cells
(ii) demonstrates that deletion of the RAP1 rhoptry signal results in inefficient rhoptry targeting and the mistargeting of the bulk of the chimeric
protein to the PV. PV staining was more obvious when the parasites were imaged without undergoing fixation.
doi:10.1371/journal.ppat.1000328.g002
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(Figure 1Aii and S3), and could be observed as a rim of
fluorescence around newly formed ring-stage parasites indicating
transfer to the PV (Figure 6iii and S3). The RAP1-444GFP
chimera appeared to be only partially localised in the rhoptry bulb
(Figure S3), but was nonetheless transferred to the PV during
invasion (Figure 6ii). These results indicate that amino acids 344-
444 of RAP1 are required for transfer of the protein to the PV.
Figure 4. Mutation of aromatic amino acids that abolishes the RAMA-RAP1 interaction also interferes with RAP1 targeting. The same
residues were mutated in the RAP1-55 targeting construct and in RAP1(22-152) recombinant protein, and the mutants were tested for their ability to
bind RAMAE in a pull-down assay (A) or to target GFP to rhoptries (B). Binding of RAMAE was detected by immunoblotting using anti-GST antibodies.
Mutated residues are shown in red. Mutation of all five aromatic residues in the RAP1 rhoptry signal completely abolished RAMAE binding and RAP1
targeting.
doi:10.1371/journal.ppat.1000328.g004
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GFP chimeras using immunoelectron microscopy were unsuccess-
ful due to the relatively low level of expression of episomal
constructs. However, our confocal microscopy results provide
preliminary evidence that amino acids 344-544 of RAP1 are
required for correct sub-organellar localisation of the protein
within the rhoptry.
Discussion
Apical organelles of apicomplexan parasites play a key role in
invasion of target cells and the subversion of host cell function.
Rhoptries of P. falciparum merozoites contain a complex proteome
including components that have been identified as potential
vaccine candidates (reviewed in [6]). However, little is known
about mechanisms of rhoptry biogenesis and discharge.
In the present study, we examined the trafficking of the rhoptry
protein RAP1. RAP1, together with RAP2 or RAP3, form the
heterodimeric LMW complex which is localised in the rhoptry
bulb of schizonts [21,23]. During invasion, the LMW complex is
secreted from the rhoptries and transferred to the PV of the
nascent ring-stage parasite [35]. Truncation of the C-terminus of
RAP1 results in disruption of its interaction with RAP2/RAP3
and causes RAP2 (and probably RAP3) to be retained in the ER
[22]. In contrast, truncated RAP1 is still targeted to rhoptries, but
is not transferred to the PV during invasion [22].
Our results confirm and expand on these earlier observations.
Using expression of GFP chimeras we were able to show that
information present between amino acids 23 and 55 of RAP1 is
necessary and sufficient for optimal targeting to the rhoptries. We
compared the RAP1 rhoptry signal to protein regions that have
been implicated in rhoptry targeting in Toxoplasma, as well as other
Plasmodium rhoptry proteins but were unable to identify a
conserved motif. This suggests that the RAP1 rhoptry signal is
specific for the LMW complex and it may be that unlike proteins
targeted to the apicoplast [41] or exported into the host RBC
Figure 5. Putative protease cleavage sites for processing of RAMA and RAP1 within the rhoptries. (A) Amino acid alignment of putative
protease cleavage sites within RAMA and RAP1. The alignment was generated using KALIGN. (B) Schematic of putative cleavage sites within RAMA
and RAP1. Red shaded areas represent the signal peptide; blue shaded areas represent the pro-peptide, green shaded area represents the GPI anchor,
and yellow shaded areas represent the mature protein. Putative cleavage sites are indicated with black arrows. The p60 RAMA cleavage site has been
mapped by N-terminal sequencing (green arrow) [39]. Cleavage of the RAP1 pro-peptide is known to occur upstream of amino acid 124 (red arrow)
[38]. RAP1 and RAMA binding sites are indicated.
doi:10.1371/journal.ppat.1000328.g005
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common targeting signal. We have provided evidence that
RAMA, a protein synthesised in the late ring stage and GPI-
anchored in the Golgi lumen, acts as an escorter for the LMW
complex via a direct association with the N-terminus of RAP1.
Bulky aromatic amino acid clusters are known to be important for
protein-protein interactions. In the case of the RAMA-RAP1
interaction, it appears that the overall organisation of aromatic
residues within the RAP1 rhoptry signal is important for correct
binding. However, in the absence of structural information, we
cannot determine whether any or all of these residues directly
contact RAMA, or whether disruption of RAMA binding and
mistargeting in our mutants occurs as a result of conformational
perturbation caused by glycine substitution.
RAP1 appears to possess a distinct signal for localisation within
the rhoptry bulb and subsequent transfer to the PV during
invasion. These findings are consistent with an earlier study in
Toxoplasma which demonstrated that the pro-domain of the
rhoptry protein ROP1 directs trafficking of a reporter to the
rhoptry neck, whereas full-length ROP1 is preferentially enriched
in the bulb [44]. The mechanism by which proteins can be
partitioned within a single membrane bound organelle is not
understood. Our data argues for the presence of a bulb-retention
motif within the C-terminus of RAP1 which may allow interaction
with other rhoptry bulb proteins (e.g. RAP2 and 23). It is worth
noting that RAP1 is a major constituent of detergent-resistant
microdomains (DRMs) in schizont stage parasites [37]. RAP1 has
no obvious lipid anchor and is likely recruited into DRMs via
association with some other protein.
Whether or not localisation of RAP1 in the rhoptry bulb is
necessary for transfer of the protein to the PV per se, is not clear.
One possibility is that rhoptry neck proteins are secreted before
rhoptry bulb proteins and are deposited onto the surface of the
target RBC. In contrast, rhoptry bulb proteins are trapped within
the PV because their secretion occurs after the formation of the
tight junction between the parasite membrane and the RBC
Figure 6. Amino acids 344-444 of RAP1 are required for the transfer of RAP1 to the PV during invasion. For the RAP1-444 (ii) and RAP1-
FL (iii) constructs, the GFP chimeras are transferred to the PV of newly formed ring stage parasites and mimic the localisation of native RAP1 in wild-
type 3D7 parasites (iv). In contrast, the RAP1-344 (i) construct is not transferred to the PV during invasion.
doi:10.1371/journal.ppat.1000328.g006
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444 of RAP1 contain a specific protein-protein interaction motif
(e.g. necessary for interaction with RAP2 and 23) which is
required for transfer to the PV. Detailed mapping of other sub-
organellar localisation signals and PV transfer signals will help to
differentiate between these two alternatives.
Based on the data presented above, we propose a model
whereby RAMA binds RAP1 in the Golgi lumen and recruits
RAP1, 22 and 23 into a complex (Figure 7). GPI-anchored
proteins have a tendency to cluster in lipid rafts, and thus the
complex is presumably anchored within a lipid raft at the Golgi
exit face [45,46]. Other proteins (e.g. the RhopH proteins which
also interact with RAMA) may be recruited into the raft as well,
thus generating rhoptry destined aggregates [15].
DRM clustering associated with protein oligomerisation has
been shown to be essential for polarised trafficking of GPI-
anchored proteins to the apical membrane in epithelial cells
(reviewed in [47,48]). Several of the known P. falciparum rhoptry
proteins, including RAMA and RAP1, are associated with DRMs
and it is tempting to speculate that this mechanism is involved in
differential sorting of proteins within the Golgi. Interestingly, none
of the known micronemal proteins have been found associated
with DRMs, whereas several merozoite surface proteins do
associate with DRMs [45]. This suggests the presence of distinct
regions of membrane at the Golgi exit face which are defined by
their protein and/or lipid composition that bud off as individual
vesicles. Each vesicle then presumably interacts with specific
components of the cellular trafficking machinery, possibly via a
transmembrane escorter. In Toxoplasma, the cytoplasmic adaptor
complex AP-1 has been implicated in rhoptry protein trafficking.
A study by Hoppe and colleagues demonstrated that AP-1 binds in
vitro to a region of the Toxoplasma rhoptry protein ROP2 that is
sufficient to mediate rhoptry targeting in vivo [18]. The biological
relevance of this finding has recently come into question as ROP2
appears to lack a transmembrane domain that is necessary in order
for the ROP2 targeting region to be exposed at the Golgi exit face
and available for binding to AP-1 [49]. Nonetheless, components
of vesicular trafficking machinery, including AP-1, have been
identified in the P. falciparum genome but their precise roles remain
to be determined (reviewed in [40]).
Upon arrival at the rhoptry, the RAMA-LMW complex is
dissociated by proteolytic cleavage [15,38]. The presence of
Figure 7. A proposed model for targeting of proteins to the rhoptries. (A) Proteins destined for the plasma membrane or the apical
organelles are co-translationally inserted into the ER and are trafficked to the Golgi. Within the Golgi, proteins destined for the rhoptries (1), the
plasma membrane (2), or the micronemes (3) aggregate into distinct sub-domains. Rhoptries and plasma membrane proteins are probably clustered
in lipid rafts whereas microneme proteins are excluded from lipid rafts. Specific escorters that are exposed on the cytoplasmic face of the Golgi recruit
adaptor and vesicle coat proteins. The sub-domains bud off as individual vesicles and are directed to their respective destinations by specific
interactions with the vesicular trafficking machinery. (B) Fusion of the vesicle with the rhoptry delivers the proteins into the rhoptry lumen. Proteolytic
processing of RAMA and RAP1 by a rhoptry resident protease releases the proteins from the transient trafficking complex. The LMW complex is
retained in the rhoptry bulb via its bulb-retention motif.
doi:10.1371/journal.ppat.1000328.g007
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suggests that a single rhoptry-resident protease is responsible for
their processing [39]. Cleavage of the N-terminus of RAP1
releases the LMW complex from RAMA. This may allow the
LMW complex to interact with other proteins in the rhoptry bulb,
potentially via the bulb-retention domain of RAP1 identified in
this study [37]. In turn, degradation of the N-terminus of RAMA
may release it from the hypothetical transmembrane escorter.
Proteins destined for the apicoplast or mitochondrion each
possess an appropriate signal that allows their post-translational
translocation into a pre-formed organelle [41,50–53]. In contrast,
many proteins destined for the apical secretory organelles appear
to be targeted by a clustering mechanism. In Toxoplasma, the
soluble microneme proteins MIC1, MIC3 and MIC4 are targeted
via an interaction with transmembrane escorter proteins [54,55].
In Plasmodium, microneme proteins of the EBL family are targeted
courtesy of a conserved luminal domain presumably via
interaction with a transmembrane escorter [56,57]. In the current
study, we present evidence that proteins can be similarly targeted
to rhoptries via the formation of transient complexes that are
packaged into transport vesicles and dissociated by proteolytic
processing upon arrival at their destination. Given that most
Plasmodium rhoptry proteins are not type 1 membrane proteins and
therefore lack a cytoplasmic tail, it is likely that targeting to
rhoptries via this mechanism is the rule rather than the exception.
Materials and Methods
Parasite cultures
P. falciparum asexual stage parasites were maintained in human
erythrocytes (blood group O+) at a hematocrit of 4% with 10%
Albumax (Invitrogen) [58]. P. falciparum 3D7 parasites were
originally obtained from David Walliker at Edinburgh University.
Cultures were synchronised as previously described [59].
Cloning
All oligonucleotide primers used in this study are listed in Table
S1. GFP fusion proteins for localization studies were encoded in
transfection constructs under the regulation of the tetracycline-
inducible expression system [26]. Regions of RAP1 were PCR
amplified from P. falciparum 3D7 genomic DNA. For mutagenesis
experiments, mutations were introduced into primers during
synthesis. PCR products were digested with PstI and MluI and
cloned in frame upstream of GFP. RAMAE1 and RAMAE2
recombinant fragments were PCR amplified from P. falciparum
cDNA and cloned as previously described [15] into the GST-
fusion vector pGEX-4T-1 (GE Healthcare). RAP1 recombinant
proteins were PCR amplified from P. falciparum 3D7 genomic
DNA. PCR products were digested with NcoI and XhoI and cloned
into the His6-fusion vector pET28b in frame upstream of the His6
tag. Constructs were sequenced and confirmed to be free of
unintended mutations.
Recombinant protein expression
His6-tagged RAP1 recombinant proteins were expressed in E.
coli BL21 (DE3) (Novagen) and purified using TALON Metal
Affinity Resin (Clontech) in accordance with manufacturer’s
instructions. RAMA-GST fusion proteins were expressed in E.
coli BL21 (DE3) and purified using glutathione resin (Sigma) as
previously described [15]. Protein expression was analysed using
SDS-PAGE and immunoblotting with anti-His6 or anti-GST
antibodies. Protein concentration was determined using the
Bradford Assay (Bio-Rad).
Pull-down assay
Purified recombinant proteins were buffer exchanged into pull-
down buffer (50 mM Na2HPO4, 75 mM NaCl, 0.1% TrionX-
100, 5 mM imidazole, pH 7.4). P. falciparum 3D7 parasites were
extracted from parasitised RBCs by lysis with 0.15% (w/v) saponin
in phosphate buffered saline and solubilised in RIPA buffer
(50 mM TrisCl (pH 8.8), 150 mM NaCl, 1% NP40, 0.5% sodium
deoxycholate, 0.1% SDS) containing Complete Mini protease
inhibitor cocktail (Roche). After lysis on ice for 5 min the insoluble
material was spun down and the supernatant collected. The
supernatant was diluted 1 part in 10 in pull down buffer prior to
use. For the pull-down assay, 100 mg of the various His6-tagged
RAP1 recombinant proteins were used as bait. These proteins
were immobilised on TALON Metal Affinity Resin (Clontech) and
incubated with either GST-fusion proteins or parasite lysate O/N
at 4uC. The resin was washed with pull-down buffer and
specifically bound proteins were eluted using imidazole (20 mM
Na2HPO4, 0.5 M NaCl, 400 mM imidazole, pH 7.4). Eluted
proteins were analysed on Coomassie stained SDS-PAGE gels and
by immunoblotting with anti-RAMA [15] or anti-GST antibodies.
Parasite Transfection
P. falciparum 3D7 parasites were transfected as described
previously [52] with 100 mg of purified plasmid DNA (Qiagen).
Positive selection for transfectants was achieved using 10 nM
WR99210 and 0.5 mg/ml Anhydrotetracycline to prevent trans-
gene expression.
Fluorescence Imaging
Anhydrotetracycline was removed from parasite cultures 72 h
prior to live imaging (in the presence of 10 nM WR99210) to allow
expression of the GFP fusion. Prior to microscopy, parasites were
incubated in culture medium containing 100 ng/ml 49,6-diami-
dino-2-phenylindole (DAPI; Roche Molecular Biochemicals).
Fluorescence images of schizont stage parasites were captured
using a Carl Zeiss Axioskop microscope with a PCO Sensicam and
Axiovision 2 software. For immunofluorescence assays, schizont
stage parasites were fixed using 4% paraformaldehyde (ProSci-
Tech) and 0.0075% glutaraldehyde (ProSciTech) as previously
described [41]. After blocking in 3% bovine serum albumin
(Sigma) the cells were incubated for 1 hour with rabbit anti-
RAMA [15], mouse anti-AMA1 [60], mouse anti-RAP1 or rabbit
anti-PfRON4 (Richard and Cowman, manuscript in preparation)
antibodies. Bound antibodies were then visualised with Alexa
Fluor-594 anti-rabbit IgG or anti-mouse IgG (Molecular Probes)
diluted 1:1000. Parasites were mounted in Vectashield (Vecta
Laboratories) containing DAPI.
Immunoelectron Microscopy
Parasites for electron microscopy immunolabeling were fixed
and prepared as described previously (Healer et al., 2002). The
primary antibodies used were mouse monoclonal anti-PfRAP-1
(1/500), rabbit anti-PfRON-4 (1/100). Samples were washed, then
incubated with secondary antibodies conjugated to either 10 nm
or 15 nm colloidal gold (BB International). Samples were then
post-stained with 2% aqueous uranyl-acetate then 5% triple lead
and observed at 120 kV on a Philips CM120 BioTWIN
Transmission Electron Microscope.
Supporting Information
Table S1 Oligonucleotide primers used in this study
Found at: doi:10.1371/journal.ppat.1000328.s001 (0.05 MB
DOC)
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with the rhoptry bulb marker RAMA
Found at: doi:10.1371/journal.ppat.1000328.s002 (1.52 MB TIF)
Figure S2 Co-localisation of RAP1 truncation-GFP fusions with
the rhoptry bulb marker RAMA. Mutated residues are shown in
parentheses.
Found at: doi:10.1371/journal.ppat.1000328.s003 (2.24 MB TIF)
Figure S3 For the RAP1-544 and RAP1-644 constructs, GFP
chimeras are localised in the rhoptry bulb (A) and are transferred
to the PV of nascent ring stage parasites (B); and, for the RAP1-
444 construct, the GFP chimera is only partially localised in the
rhoptry bulb.
Found at: doi:10.1371/journal.ppat.1000328.s004 (2.12 MB TIF)
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